Counseling on Injectable Contraception and HIV Risk in Tanzania
2019年11月8日 更新者:University of North Carolina, Chapel Hill
Counseling on Injectable Contraception and HIV Risk: Evaluation of a Pilot Intervention in Tanzania
The main objective of the evaluation was to assess the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and behavior during a three month pilot intervention in ten healthcare facilities in Tanzania.
研究概览
详细说明
The evaluation assessed the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and uptake during a three month pilot intervention.
The intervention was conducted September-November 2018 in ten healthcare facilities located in the Iringa and Njombe regions of Tanzania.
Data collection for the evaluation occurred November-December 2018 and included 471 client exit interviews, 26 healthcare provider interviews, and the extraction of monthly aggregate service statistics for 12 months prior to the intervention and three months of the intervention.
Univariate and bivariate analyses were used to assess quantitative interview data.
Thematic qualitative assessment was used to assess qualitative interview data from healthcare providers.
Interrupted time series analysis was used to assess changes in the trend of monthly contraceptive uptake.
研究类型
观察性的
注册 (实际的)
10
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Iringa、坦桑尼亚
- Ihongole Health Center
-
Iringa、坦桑尼亚
- Ipogolo Health Center
-
Iringa、坦桑尼亚
- Kimande Health Center
-
Njombe、坦桑尼亚
- Ipelele Health Center
-
Njombe、坦桑尼亚
- Kibena Regional Referral Hospital
-
Njombe、坦桑尼亚
- Makambako Hospital
-
Njombe、坦桑尼亚
- Makete Hospital
-
Njombe、坦桑尼亚
- Njombe Health Center
-
-
Iringa
-
Ilula、Iringa、坦桑尼亚
- Ilula Hospital
-
Mafinga、Iringa、坦桑尼亚
- Mafinga Hospital
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
15年 至 49年 (孩子、成人)
接受健康志愿者
不适用
有资格学习的性别
女性
取样方法
非概率样本
研究人群
All women attending a participating healthcare facility during the three month intervention period and who met eligibility criteria received the hormonal contraception and HIV risk messages.
描述
Inclusion Criteria:
- Expressed interest in injectable use
- HIV-negative or unknown HIV status
Exclusion Criteria:
- Positive HIV status known to healthcare provider
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of clients obtaining an injectable during their family planning appointment
大体时间:After implementation of counseling messages, up to 13 weeks
|
Injectable uptake of interviewed clients
|
After implementation of counseling messages, up to 13 weeks
|
|
Percent of clients obtaining an injectable during their family planning appointment
大体时间:After implementation of counseling messages, up to 13 weeks
|
Injectable uptake of interviewed clients
|
After implementation of counseling messages, up to 13 weeks
|
|
Monthly total number of family planning clients by method obtained
大体时间:September 2017 through November 2018
|
Contraceptive uptake during pilot intervention
|
September 2017 through November 2018
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall
大体时间:After implementation of counseling messages, up to 13 weeks
|
Knowledge of hormonal contraception and HIV risk messages
|
After implementation of counseling messages, up to 13 weeks
|
|
Percent of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall
大体时间:After implementation of counseling messages, up to 13 weeks
|
Knowledge of hormonal contraception and HIV risk messages
|
After implementation of counseling messages, up to 13 weeks
|
|
Number of correct True/False statements on hormonal contraception and HIV (11 total)
大体时间:After implementation of counseling messages, up to 13 weeks
|
Knowledge of hormonal contraception and HIV risk messages
|
After implementation of counseling messages, up to 13 weeks
|
|
Percent of correct True/False statements on hormonal contraception and HIV (11 total)
大体时间:After implementation of counseling messages, up to 13 weeks
|
Knowledge of hormonal contraception and HIV risk messages
|
After implementation of counseling messages, up to 13 weeks
|
|
Number of interviewed clients reporting an intention to use condoms as a dual method
大体时间:After implementation of counseling messages, up to 13 weeks
|
Intention to use condoms as a dual method
|
After implementation of counseling messages, up to 13 weeks
|
|
Percent of interviewed clients reporting an intention to use condoms as a dual method
大体时间:After implementation of counseling messages, up to 13 weeks
|
Intention to use condoms as a dual method
|
After implementation of counseling messages, up to 13 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
合作者
调查人员
- 首席研究员:Janine Barden-O'Fallon, PhD、University of North Carolina, Chapel Hill
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2018年9月1日
初级完成 (实际的)
2018年11月30日
研究完成 (实际的)
2018年11月30日
研究注册日期
首次提交
2019年11月7日
首先提交符合 QC 标准的
2019年11月8日
首次发布 (实际的)
2019年11月12日
研究记录更新
最后更新发布 (实际的)
2019年11月12日
上次提交的符合 QC 标准的更新
2019年11月8日
最后验证
2019年11月1日
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
是的
IPD 计划说明
Deidentified data from the client interviews are publicly available through MEASURE Evaluation Dataverse in STATA format.
The study report is also available on Dataverse.
IPD 共享时间框架
Data are currently available and will remain on Dataverse.org
IPD 共享访问标准
Site registration required.
IPD 共享支持信息类型
- 企业社会责任
研究数据/文件
-
个人参与者数据集
信息标识符:doi:10.15139/S3/XEXQXO
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.